Skip to Content

Bromocriptine

In some countries, this medicine may only be approved for veterinary use.

In the US, Bromocriptine (bromocriptine systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, prolactin inhibitors and is used to treat Acromegaly, Diabetes - Type 2, Hyperprolactinemia, Parkinson's Disease and Tardive Dyskinesia.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G02CB01,N04BC01

CAS registry number (Chemical Abstracts Service)

0025614-03-3

Chemical Formula

C32-H40-Br-N5-O5

Molecular Weight

654

Therapeutic Categories

Treatment of Parkinson's disease

Dopamine agonist

Lactation suppressant

Prolactin inhibitor

Chemical Name

2-bromo-α-ergocryptine (WHO)

Foreign Names

  • Bromocriptinum (Latin)
  • Bromocriptin (German)
  • Bromocriptine (French)
  • Bromocriptina (Spanish)

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide